Crossmark

Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis

Crossref DOI link: https://doi.org/10.1186/s40560-022-00619-2

Published Online: 2022-06-11

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Reuken, Philipp A.

Brozat, Jonathan F.

Quickert, Stefanie

Ibidapo-obe, Oluwatomi

Reißing, Johanna

Franz, Anika

Stengel, Sven

Teichgräber, Ulf K.-M.

Kiehntopf, Michael

Trautwein, Christian

Stallmach, Andreas

Koch, Alexander

Bruns, Tony https://orcid.org/0000-0002-5576-6914
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (403224013/B07)

RWTH Aachen University
License Information

Text and Data Mining valid from 2022-06-11

Version of Record valid from 2022-06-11
More Information

Article History

Received: 5 January 2022

Accepted: 30 May 2022

First Online: 11 June 2022

Declarations

:

: All patients, next of kin or legal guardians gave written informed consent according to the study protocols prior to inclusion as approved by the respective internal review boards and ethics committee (5128-03/17, Jena and EK 150/06, Aachen).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below